Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Oral probiotics can resolve urogenital infections.

Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B.

FEMS Immunol Med Microbiol. 2001 Feb;30(1):49-52.

2.

Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review.

Barrons R, Tassone D.

Clin Ther. 2008 Mar;30(3):453-68. doi: 10.1016/j.clinthera.2008.03.013. Review.

PMID:
18405785
3.

Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women.

Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, Bruce AW.

FEMS Immunol Med Microbiol. 2003 Mar 20;35(2):131-4.

4.

Probiotics for the treatment of women with bacterial vaginosis.

Falagas M, Betsi GI, Athanasiou S.

Clin Microbiol Infect. 2007 Jul;13(7):657-64. Review.

5.

Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora.

Reid G, Beuerman D, Heinemann C, Bruce AW.

FEMS Immunol Med Microbiol. 2001 Dec;32(1):37-41.

6.

Probiotic agents to protect the urogenital tract against infection.

Reid G.

Am J Clin Nutr. 2001 Feb;73(2 Suppl):437S-443S. Review.

7.

Probiotics to prevent urinary tract infections: the rationale and evidence.

Reid G, Bruce AW.

World J Urol. 2006 Feb;24(1):28-32. Epub 2005 Dec 31. Review.

PMID:
16389539
8.

Lactobacilli for prevention of urogenital infections: a review.

Marelli G, Papaleo E, Ferrari A.

Eur Rev Med Pharmacol Sci. 2004 Mar-Apr;8(2):87-95. Review.

PMID:
15267122
9.

Probiotics for urogenital health.

Reid G.

Nutr Clin Care. 2002 Jan-Feb;5(1):3-8. Review.

PMID:
12134717
10.

[Use of Lactobacillus as a probiotic factor to treat urogenital and intestinal infections as well as to prevent and treat allergic diseases].

Merk K, Borelli C, Schaller M, Korting HC.

J Dtsch Dermatol Ges. 2004 Sep;2(9):752-7. Review. German.

PMID:
16279218
11.

Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial.

Martinez RC, Franceschini SA, Patta MC, Quintana SM, Gomes BC, De Martinis EC, Reid G.

Can J Microbiol. 2009 Feb;55(2):133-8. doi: 10.1139/w08-102.

PMID:
19295645
12.
13.

Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis.

Anukam KC, Osazuwa E, Osemene GI, Ehigiagbe F, Bruce AW, Reid G.

Microbes Infect. 2006 Oct;8(12-13):2772-6. Epub 2006 Sep 11.

PMID:
17045832
14.

Probiotic Lactobacilli for urogenital health in women.

Reid G.

J Clin Gastroenterol. 2008 Sep;42 Suppl 3 Pt 2:S234-6. doi: 10.1097/MCG.0b013e31817f1298. Review.

PMID:
18685506
15.
16.

Studies on the effects of probiotic Lactobacillus mixture given orally on vaginal and rectal colonization and on parameters of vaginal health in women with intermediate vaginal flora.

Strus M, Chmielarczyk A, Kochan P, Adamski P, Chełmicki Z, Chełmicki A, Pałucha A, Heczko PB.

Eur J Obstet Gynecol Reprod Biol. 2012 Aug;163(2):210-5. doi: 10.1016/j.ejogrb.2012.05.001. Epub 2012 Jun 19.

PMID:
22721635
17.

Targeting the vaginal microbiota with probiotics as a means to counteract infections.

Reid G, Dols J, Miller W.

Curr Opin Clin Nutr Metab Care. 2009 Nov;12(6):583-7. doi: 10.1097/MCO.0b013e328331b611. Review.

PMID:
19741517
18.

[Efficacy of Lactobacillus Rhamnosus GR-1 and of Lactobacillus Reuteri RC-14 in the treatment and prevention of vaginoses and bacterial vaginitis relapses].

Cianci A, Giordano R, Delia A, Grasso E, Amodeo A, De Leo V, Caccamo F.

Minerva Ginecol. 2008 Oct;60(5):369-76. Italian.

PMID:
18854803
19.

Urogenital infections in women: can probiotics help?

Reid G, Bruce AW.

Postgrad Med J. 2003 Aug;79(934):428-32. Review.

20.

Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli.

Cadieux PA, Burton J, Devillard E, Reid G.

J Physiol Pharmacol. 2009 Dec;60 Suppl 6:13-8.

Supplemental Content

Support Center